| Stage | WMT | % of rev | PFE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $188B | 100.00% | $16.6B | 100.00% | WMT ×11.33 |
| Gross profit | $49.1B | 26.14% | $12.6B | 75.71% | PFE +49.6pp |
| Operating income | $9.4B | 4.99% | $3.7B | 22.14% | PFE +17.2pp |
| Pre-tax income | $8.0B | 4.26% | $3.4B | 20.41% | PFE +16.1pp |
| Net income | $6.5B | 3.47% | $3.3B | 19.61% | PFE +16.1pp |
| Stage | WMT | PFE | Gap · A − B |
|---|---|---|---|
| Revenue | $188B100.00% | $16.6B100.00% | WMT ×11.33 |
| Gross profit | 26.14%$49.1B | 75.71%$12.6B | PFE +49.6pp |
| Operating income | 4.99%$9.4B | 22.14%$3.7B | PFE +17.2pp |
| Pre-tax income | 4.26%$8.0B | 20.41%$3.4B | PFE +16.1pp |
| Net income |
| 3.47%$6.5B |
| 19.61%$3.3B |
| PFE +16.1pp |
No shared counterparties.